CST1 and gastric cancer: Serum ELISA assay in 50 normal people, 45 stage I-II GC patients, and 30 stage III-IV GC patients revealed that CST1 was highly expressed in GC patients’ serum compared with normal people and highly consistent with patient’s clinicopathological stage (p < 0.0001, Fig. 8E).